RHHVF:OTCMKTS
Roche Holding AG Genussscheine
438,07 USD
arrow_upward
+1,80%(+7,75) 1D
13-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHVF...
Open
434,00 USD
High
445,00 USD
Low
430,00 USD
Mkt. cap
349,83 млд
Avg. vol.
4,73 миң
Volume
223,00
52-wk high
490,33 USD
52-wk low
318,81 USD
Beta
0,51
Shares outstanding
702,56 млн
No. of employees
113 миң
Open
434,00 USD
High
445,00 USD
Low
430,00 USD
Mkt. cap
349,83 млд
Avg. vol.
4,73 миң
Volume
223,00
52-wk high
490,33 USD
52-wk low
318,81 USD
Beta
0,51
Shares outstanding
702,56 млн
No. of employees
113 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
3 саат мурун
Hapvida signs Roche deal: target for Hapvida stock falls 10.77 percent
Reuters
·
13 саат мурун
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Euronext Markets: Real-time Stock Market Data | live
·
13 саат мурун
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
ad-hoc-news.de
·
14 саат мурун
Roche Holding stock rises 3.44 percent on SIX
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113 миң
Founded1896-ж., 1-окт.
HeadquartersБазель, Базель-Штадт, Швейцария
SectorPharmaceutical industry
Websiteroche.com